Advisors Asset Management, Inc. Alkermes Plc. Transaction History

Advisors Asset Management, Inc.

$5.23 Billion
Q4 2024

A detailed history of Advisors Asset Management, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 14,144 shares of ALKS stock, worth $383,443. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,144

Previous 10,158 39.24%

Holding current value

$383,443

Previous $284,000 42.96%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$25.7 - $31.46 $102,440 - $125,399	3,986 Added 39.24%	14,144 $406,000
Q3 2024 Nov 08, 2024	BUY	$23.01 - $28.55 $40,750 - $50,562	1,771 Added 21.12%	10,158 $284,000
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $498,991 - $585,632	-21,499 Reduced 71.94%	8,387 $202,000
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $129,122 - $159,250	4,891 Added 19.57%	29,886 $809,000
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $18,368 - $22,542	-786 Reduced 3.05%	24,995 $693,000
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $19,951 - $23,675	-704 Reduced 2.66%	25,781 $806,000
Q1 2023 May 12, 2023	SELL	$25.31 - $29.02 $21,412 - $24,550	-846 Reduced 3.1%	26,485 $746,000
Q3 2022 Nov 08, 2022	BUY	$22.0 - $31.87 $74,734 - $108,262	3,397 Added 18.02%	22,249 $497,000
Q2 2022 Aug 08, 2022	BUY	$26.4 - $30.54 $497,692 - $575,740	18,852 New	18,852 $562,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $35,000 - $43,558	-1,794 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $29,650 - $51,552	-1,381 Reduced 43.5%	1,794 $40,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $40,526 - $52,071	-1,427 Reduced 31.01%	3,175 $116,000
Q4 2018 Jan 31, 2019	SELL	$27.94 - $44.61 $48,028 - $76,684	-1,719 Reduced 27.2%	4,602 $136,000
Q3 2018 Nov 15, 2018	SELL	$38.6 - $46.12 $25,128 - $30,024	-651 Reduced 9.34%	6,321 $268,000
Q2 2018 Aug 22, 2018	SELL	$40.56 - $51.36 $48,509 - $61,426	-1,196 Reduced 14.64%	6,972 $287,000
Q2 2018 Aug 15, 2018	SELL	$40.56 - $51.36 $269,521 - $341,287	-6,645 Reduced 44.86%	8,168 $287,000
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $4,932 - $6,187	-92 Reduced 0.62%	14,813 $846,000
Q4 2017 Feb 13, 2018	SELL	$47.69 - $55.39 $29,472 - $34,231	-618 Reduced 3.98%	14,905 $816,000
Q3 2017 Nov 07, 2017	BUY	$49.16 - $54.45 $763,110 - $845,227	15,523	15,523 $789,000

Others Institutions Holding ALKS

# of Institutions

385

Shares Held

166M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.45B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Alkermes Plc. Transaction History